Complementing our in-house expertise with the know-how of excellent partners from academia and industry is an integral part of the innovation strategy at Bayer. The company offers many different forms of cooperation along the value-chain, from traditional licensing agreements or strategic research alliances to public-private partnerships as well as crowdsourcing. Our new website innovate.bayer.com is a central point of contact for Open Innovation offers.
Bayer’s global open innovation approach includes a number of successful crowdsourcing and co-working initiatives as well as the CoLaborator™. Together with bright minds outside of Bayer, we join forces to develop new therapeutic options for the benefit of patients and generate ideas in new crop protection.
Working with people from research and development outside the Bayer organization is an important source of innovation for all our divisions. Grants4Targets™ was introduced in 2009 and marks the first crowdsourcing program at Bayer. Further initiatives of this kind have been established since then: Grants4Apps™, Grants4Indications™, PartnerYourAntibodies™ as well as Grants4Tech™ and Grants4Traits™. In the context of open innovation Bayer offers grants for scientists from universities, academic research institutes, and startup companies or health-IT developers from all over the world to support specific projects. The participants are supported through funding and they can benefit - depending on the program - from work accommodations and the expertise of Bayer researchers in Life Sciences.